3. Boston Scientific
$19.4 million in research payments to doctors and teaching hospitals (2018)
Big 100 rank: 14
1.7% of R&D spending ($1.113 billion)
0.2% of annual revenue ($9.823 billion)
Top doctor payments
The top five payments to physicians in the U.S. totaled $23,831 and went toward pelvic organ prolapse and pain management devices.
- $7,797 associated with a research of study involving the Uphold Lite vaginal support system (Note: FDA ordered Boston Sci to stop selling the surgical mesh system last year.);
- $7,765 for a pain management research study;
- $3,369 related to an Uphold Lite research study;
- $2,500 related to a Spectra Wavewriter pain management research study;
- $2,400 associated with a pelvic organ prolapse study involving Xenform, which Boston Sci also pulled form the market last year.
Top teaching hospital payments
The top five payments to teaching hospitals in the U.S. totaled $1,384,502 and went toward structural heart, stents and diagnostic devices.
- $819,625 involving a Watchman structural heart device research study;
- $221,425 related to a Synergy stent research study;
- $143,452 associated with a Synergy stent research study;
- $100,000 in two individual payments involving a Rhythmia diagnostic device research study.